Actively Recruiting
The Study to Evaluate the Safety and Efficacy of the Onyx Family
Led by Pusan National University Yangsan Hospital · Updated on 2024-09-19
500
Participants Needed
1
Research Sites
238 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Observation of the safety and efficacy of 1-month dual antiplatelet therapy (DAPT) after percutaneous coronary intervention using Onyx family stents in elderly patients aged 75 years or older
CONDITIONS
Official Title
The Study to Evaluate the Safety and Efficacy of the Onyx Family
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Aged 75 or more
- Eligible for interventional procedures
- Evidence of myocardial ischemia or coronary artery stenosis 250%
- Able to take antiplatelet therapy for at least 1 month after the procedure
- Underwent coronary artery procedures with Zotarolimus-eluting stents (Onyx family, Medtronic)
You will not qualify if you...
- Known hypersensitivity or contraindication to heparin, aspirin, clopidogrel, zotarolimus, or contrast media (except patients with contrast media sensitivity that can be premedicated)
- Active pathological bleeding
- Gastrointestinal or genitourinary bleeding within prior 3 months
- Major surgery within 2 months
- History of bleeding disorders or known coagulopathy, including heparin-induced thrombocytopenia
- Noncardiac conditions with life expectancy less than 1 year or that may cause protocol noncompliance
- Actively participating in another investigational drug or device study without completed primary endpoint follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, South Korea, 50611
Actively Recruiting
Research Team
M
Min Ku Chon, MD,PhD
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here